Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines

Details for Australian Patent Application No. 2005218319 (hide)

Owner Metaproteomics, LLC

Inventors Tripp, Matthew L.; Babish, John G.; Bland, Jeffrey S.

Agent Davies Collison Cave

Pub. Number AU-B-2005218319

PCT Pub. Number WO2005/084230

Priority 10/789,817 27.02.04 US

Filing date 26 February 2005

Wipo publication date 15 September 2005

Acceptance publication date 16 June 2011

International Classifications

A61K 31/12 (2006.01) - Ketones

A61K 31/19 (2006.01)

A61K 31/522 (2006.01)

A61K 31/557 (2006.01) - Eicosanoids, e.g. leukotrienes

A61K 36/185 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines - Magnoliopsida (dicotyledons)

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/084230 Priority application(s): WO2005/084230

16 June 2011 Application Accepted

  Published as AU-B-2005218319

13 October 2011 Standard Patent Sealed

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005218322-Method and system for collecting online merchandising data

2005218318-Methods and devices for reducing hollow organ volume